Today’s AI Top Pick: ADMA

7/6/2026 · Short-Term Bounce 🧪 <= 20 screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Short-Term Bounce 🧪 <= 20ADMABUY NOW8.7 / 107/6/2026

ADMA is the standout: it's the only name in the pool where genuinely elite fundamentals meet a fully-aligned bullish tape and asymmetric forecast magnitudes. Fundamentals are best-in-class here — PE 13.2, fwdPE 9.29, PEG 0.32, ROE 43.3, profit margin 32.43%, operating margin 40.57%, debt/equity 0.52, and institutional ownership 91.91%. Analyst recom 1.75 with a targetUpsidePct of 98.3% — the sell side thinks fair value is roughly double today's 9.05 print. Fundamental_score of 8 (tied for the top of the pool). The multi-timeframe tape confirms: bullish_prob = 1.0, near_term_bullish = 1.0. Daily forecasts are the loudest signal in the whole pool — fc_short +89.48%, fc_mid +61.78%, fc_long +41.33%. The 4h stack (+9.22 / +67.36 / +162.79) and 1h (+15.73 long) agree in direction. Crucially, this is NOT a chase: on the weekly timeframe the stock is at pos_in_21bar_range_pct = 12.66% with a -44.92% drawdown from the 21-bar high. So while 1h/4h/1d show a fresh breakout (pos 100%), the higher-timeframe context says this is a deeply oversold name (YTD -50.93%, 1Y -50.66%) just beginning to mean-revert — exactly the short_term_bounce_20 setup this lens is designed to catch. Recent headlines are benign-to-mildly-positive (MarketBeat flagged ADMA as a biotech with 'major potential catalysts in the coming months'; no guidance cuts, no dilution, no short-seller reports). Compare that to alternatives: HBAN, VLY, NWG, SAN, LYG all have bullish_prob = 0 with sharply negative weekly forecasts (-17% to -46% fc_short); SGHC/FLYW/GRND are at 100% of range with negative multi-TF forecasts (classic chase-and-fade); PAYO was just downgraded by Benchmark and Citi; WTTR's 1d/1wk forecasts are -36% to -49%. DNOW and ATHM are the only other bullish_prob=1 names, but DNOW has negative margins and a null trailing PE, while ATHM has only 2.6% analyst upside and just took a Citi target cut on revenue-growth concerns. Today is the entry, not a pullback wait: the daily and 4h are already breaking out (pos 100%, dd 0%) with forecast momentum accelerating, and the weekly deep-drawdown context means there's structural room to run before hitting resistance. Waiting risks missing the initial impulse leg on a name where the tape says +40-60% is on the table in the mid horizon.

Entry zone

$8.85 - $9.15 (buy at market near 9.05, add on any intraday dip to 8.85 which is just below the 1h breakout base)

Stop loss

$7.95 (approx -12%, below the recent consolidation floor and beneath the round $8 psychological level; weekly dd already -44.9% so anything below $8 breaks the bounce thesis)

First target

$11.00 (+21%, aligns with the 4h fc_short and the gap-fill zone from the prior selloff)

Longer target

$13.50 - $15.00 (+50-66%, tracks the 1d fc_mid ~+62% and 1wk fc_long +26%; still well below the analyst target implied upside of 98%)

Risks

Weekly drawdown of -44.92% and 1Y perf of -50.66% mean this is a knife-catch — if the weekly downtrend resumes, the -44% context can extend quickly
Short float 9.45% is manageable but a failed bounce can trigger fresh shorting given the broken chart
Biotech/plasma-therapy single-product concentration risk — any regulatory or reimbursement headline can gap the stock 10%+ overnight
1h/4h/1d all sit at pos_in_range = 100%, so on the very short term you ARE buying an extension; a 3-5% pullback in the first 1-2 sessions is entirely normal
Forecast magnitudes (1d fc_short +89%, 4h fc_long +163%) are extreme outliers — if the model is over-fit to the bounce, actual follow-through could be materially smaller

Honorable mentions

ATHMBullish_prob 1.0, strong 1d (+27/+16/+24) and 1wk (+30/+47/+50) forecasts, clean balance sheet (debt/eq 0), PE 14 / fwdPE 13.4, but analyst targetUpside only 2.6% and Citi just cut the target citing revenue-growth concerns — the tape is better than the fundamental narrative

DNOWBullish_prob 1.0, near_term 1.0, recom 1.0 (strong buy), two fresh Buy initiations (DA Davidson, Freedom Broker), and RSI 38.84 = genuine oversold. Held back by negative operating margin (-2.23%), null trailing PE, and only modest forecast magnitudes (1d fc_mid +5.76%)

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	ADMA	BUY NOW	8.7	Bullish_prob 1.0 + fundamental_score 8 + 1d fc_short +89% + weekly pos_in_range 12.66% = the cleanest bounce setup in the pool.
2	ATHM	BUY NOW	7.2	Prob 1.0 with big 1wk forecasts (+30/+47/+50) and zero debt, but Citi target cut and 2.6% analyst upside cap the conviction.
3	DNOW	BUY NOW	6.6	Prob 1.0, RSI 38.8, two fresh Buy initiations, recom 1.0 — modest forecast magnitudes but a clean oversold industrials bounce.
4	LYFT	BUY PULLBACK	6.1	Prob 0.6, PE 2.16, 4h fc_long +41% and 1wk fc_long +40.87%, but 1h/4h/1d all at 97-99% of range — wait for a dip.
5	VRDN	BUY PULLBACK	5.6	FDA approval catalyst for Lumvoa + RBC PT raise, 4h fc_mid/long +40%, but near_term_bullish 0 and profit margin -482%.
6	SOFI	WAIT	5.3	Prob 0.4, mixed forecasts, near 96% of 1d range after already dropping 32% H1 — no edge here today.
7	SGRY	BUY PULLBACK	5.1	1wk fc_long +75%, near_term 0.6, but RSI 75.7, pos 100% across all TFs and fundamental_score only 0.25.
8	RNW	WAIT	4.9	Fundamental_score 7.25 and Zacks upgrade, but prob only 0.2 and mid/long forecasts mixed to negative.
9	CLSK	WAIT	4.6	RSI 32.7 is deeply oversold and 1h fc_mid +29.8%, but prob 0, negative margins, and Simply Wall St flagging 'above fair value.'
10	EQPT	WAIT	4.4	1h fc's positive (+9/+18/+16) after -23% drop, but Umibōzu short-seller report is a landmine and only 1h data available.
11	AUPH	WAIT	4.2	Zacks Strong Buy upgrade, PE 7.2, profit margin 100%, but prob 0 and 1d/1wk forecasts sharply negative (-21%, -34%).
12	KYIV	WAIT	3.9	AI/telecom narrative solid, but bullish_prob null and all forecasts -10% to -38%.
13	PAYO	AVOID	3.6	Benchmark and Citigroup both downgraded in June, prob 0, fc_mid -30%.
14	BGC	WAIT	3.5	Prob 0, 1d/1wk forecasts -13% to -31%, and Q2 guidance affirmation was only in-line.
15	FRMI	WAIT	3.4	AI-data-center narrative attractive but null fundamentals, prob null, and 1h forecast -25% mid.
16	BBAR	WAIT	3.3	PEG 0.17 is cheap but prob 0 and 1wk fc_mid/long both around -43%.
17	HBAN	AVOID	3.2	Prob 0, at 100% of 1d range with 1wk fc_mid -26.18% — top-of-range fade risk despite good fundamentals.
18	FNB	AVOID	3.0	Prob 0, 1d/1wk forecasts -13% to -28%; nothing bullish on the tape.
19	DHT	AVOID	2.9	1d fc_short -17.95%, 1wk fc_mid -40.54%, and epsNextY -41%; tanker cycle looks like it's rolling over.
20	SHC	AVOID	2.9	Prob 0, at 100% of range across all TFs, fc_mid -17.58% on daily.
21	VLY	AVOID	2.8	Prob 0, 1d fc_short -25.85%, 1wk fc_mid -40.68% — regional-bank forecast tape is broken.
22	NWG	AVOID	2.7	Prob 0, at 100% of range on every TF, 1wk fc_mid -63.19%.
23	LYG	AVOID	2.6	Prob 0, 1wk fc_short -46%, fc_mid -49% — clear top.
24	GRND	AVOID	2.5	RSI 77.85, 1wk perf +56%, 1wk fc_mid -30.5% — classic overextension after Morgan Stanley upgrade.
25	FLYW	AVOID	2.4	At 100% across all TFs after +68% weekly move, insider selling, and 1d fc_short -19%.
26	SGHC	AVOID	2.3	1wk +54.5% into 100% of range, then fc_mid -62.38% — textbook blowoff.
27	SAN	AVOID	2.2	At 100% of range on every TF, 1wk fc_mid -54%; the bank rally is exhausted.
28	WTTR	AVOID	2.0	1d fc_short -36%, fc_long -40%, 1wk fc_long -49% after +71% YTD — reversion trade to the downside.
29	AAL	AVOID	2.0	RSI 75.18, PE 58.5, thin 0.36% profit margin, and airlines look topped.
30	AEG	AVOID	2.0	Prob 0, epsNextY -0.74, and 4% analyst upside — no catalyst, no tape.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord